VHL-pGex2TK Citations (4)
Originally described in: Tumour suppression by the human von Hippel-Lindau gene product.Iliopoulos O, Kibel A, Gray S, Kaelin WG Nat Med. 1995 Aug . 1(8):822-6. PubMed Journal
Articles Citing VHL-pGex2TK
| Articles |
|---|
| Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein. Minervini G, Mazzotta GM, Masiero A, Sartori E, Corra S, Potenza E, Costa R, Tosatto SC. Sci Rep. 2015 Jul 27;5:12605. doi: 10.1038/srep12605. PubMed |
| An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs. Bondeson DP, Smith BE, Buhimschi AD. Methods Mol Biol. 2021;2365:135-150. doi: 10.1007/978-1-0716-1665-9_7. PubMed |
Characterization of PROTAC specificity and endogenous protein interactomes using ProtacID.
Shrestha S, Maitland MER, Jing L, Duan S, Nie DY, St-Germain J, Kanaris M, Barsyte-Lovejoy D, Arrowsmith CH, Raught B.
Nat Commun. 2025 Aug 29;16(1):8089. doi: 10.1038/s41467-025-63357-7.
PubMed
Associated Plasmids |
| Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt/beta-catenin signaling. Wang Y, Yao Y, Liu Z, Long S, Yi F, Fang Q, Wu D, Zhu Q, Zai H, Xiao S, Wan F, Fu K. Nat Commun. 2025 Sep 29;16(1):8598. doi: 10.1038/s41467-025-63685-8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.